Literature DB >> 31821583

Update on the pathology, genetics and somatic landscape of sebaceous tumours.

Ingrid Ferreira1,2, Katharina Wiedemeyer3,4, Pieter Demetter5, David J Adams2, Mark J Arends6, Thomas Brenn4,6.   

Abstract

Cutaneous sebaceous neoplasms show a predilection for the head and neck area of adults and include tumours with benign behaviour, sebaceous adenoma and sebaceoma, and sebaceous carcinoma with potential for an aggressive disease course at the malignant end of the spectrum. The majority of tumours are solitary and sporadic, but a subset of tumours may be associated with Lynch syndrome, also known as hereditary non-polyposis colon cancer (HNPCC) and previously referred to as Muir-Torre syndrome (now known to be part of Lynch syndrome). This review provides an overview of the clinical and histological features of cutaneous sebaceous neoplasia with an emphasis on differentiating features and differential diagnosis. It also offers insights into the recently described molecular pathways involved in the development of sebaceous tumours and their association with Lynch syndrome.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  Lynch syndrome; Muir-Torre syndrome; Sebaceous neoplasms; sebaceoma; sebaceous adenoma; sebaceous carcinoma

Year:  2020        PMID: 31821583     DOI: 10.1111/his.14044

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

1.  A skin-colored nodule on the scalp of a woman.

Authors:  Chirag Ashwin Desai; Naguesh Pai Kakode
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021-04-23       Impact factor: 2.545

Review 2.  Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors.

Authors:  Julie Leclerc; Catherine Vermaut; Marie-Pierre Buisine
Journal:  Cancers (Basel)       Date:  2021-01-26       Impact factor: 6.639

3.  Case Report: A Frameshift Mutation in MSH2 Exon 2 in a Kidney Recipient With Muir-Torre Syndrome.

Authors:  Yifei Feng; Jianqing Feng; Jianrong Bao
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.